{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6O0JDA","lastupdate":"2020-09-21T00:00:00.000Z","update_date":"2020-09-21T00:00:00.000Z","lastModified":"May 29, 2025","active":1,"confidence_score":94,"confidence_score_reason":"markets, not claimed","urlname":"glassesoff","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$uCrHHdpKMqY2DZW9ObBOZ2ibQrkVXk9cNPkonjEtBHlCElCYzzKvhr","name":"Innovision Labs","oneliner":"Enhancing Human Image Processing","registrar":"514002658","website":"https://glassesoff.com/cgi-sys/suspendedpage.cgi","careerspage":"http://www.glassesoff.com/careers","founded_month":2,"founded_year":2007,"formernames":["GlassesOff"],"sociallinks":{"twitter":"https://twitter.com/GlassesOff_App","youtube":"https://www.youtube.com/channel/UCLymrSw_6rthpdPiEpJEtyA","facebook":"https://www.facebook.com/GlassesOff","linkedin":"https://www.linkedin.com/company/10448121","instagram":""},"social":["https://www.facebook.com/GlassesOff","https://apps.apple.com/app/glassesoff/id733557543","https://play.google.com/store/apps/details?id=com.glassesoff.android","https://twitter.com/GlassesOff_App","https://www.linkedin.com/company/10448121","https://www.youtube.com/channel/UCLymrSw_6rthpdPiEpJEtyA"],"flattenedsociallinks":"https://www.facebook.com/GlassesOff|https://apps.apple.com/app/glassesoff/id733557543|https://play.google.com/store/apps/details?id=com.glassesoff.android|https://twitter.com/GlassesOff_App|https://www.linkedin.com/company/10448121|https://www.youtube.com/channel/UCLymrSw_6rthpdPiEpJEtyA","apps":{"appstore":"https://apps.apple.com/app/glassesoff/id733557543","googleplay":"https://play.google.com/store/apps/details?id=com.glassesoff.android"},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":11,"patent":1,"raised":23100000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["GlassesOff"],"about":"Innovision Labs is a neuroscience technology company focused on enhancing image-processing functions in the human vision system. The company's team uses breakthroughs in visual neuroscience to improve vision performance and to provide accessible, intuitive, vision-based diagnostic tools. The company's two products, GlassesOff and Game Vision, were developed by Eyekon E.R.D.\r\n\r\nGlassesOff is a mobile application for iOS and Android designed for people with presbyopia (natural, age-related farsightedness). The application exercises the visual cortex of the brain through a game-like experience to help improve vision sharpness. GlassesOff is a personalized product that monitors user performance and constantly adjusts according to each user's ongoing progress.\r\n\r\nGame Vision is a mobile application for iOS and Android created for athletes who play sports requiring rapid image processing. Game Vision helps athletes improve their sports vision, which is critical for on-court and on-field performance. The application was designed with a specific emphasis on boosting the brain's image-processing speed, depth perception, sharpness of vision, and contrast sensitivity through mobile game challenges that contain specific game elements and logic interpreted by a scientific algorithm.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"496f71a3-a35d-4ddb-97bb-f469918cbe47","city":"Giv'atayim","type":null,"address":"Jabotinsky 5, Ramat Gan, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"308972f4-0a05-4536-a4b1-ecf5d688e6ab","date":"Mar 3, 2016","link":"http://www.prnewswire.com/news-releases/nine-time-all-star-chris-paul-and-innovision-labs-launch-game-vision-app-by-chris-paul-300230253.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["neuroscience technology","sports vision","image processing speed","mobile app"],"company":"InnoVision Labs","layoffs":null,"summary":"InnoVision Labs, a neuroscience technology company, has launched the Game Vision by Chris Paul app. The app, available on iPhone/Android platforms, is designed to improve the image processing speed of athletes by up to 2x. It uses patented and proprietary neuroscience technology developed by InnoVision Labs team of neuroscientists and game logic themes designed by a team of mobile game experts, in partnership with Chris Paul. The app is expected to provide athletes with a unique competitive edge by enhancing their sports vision. InnoVision Labs technology has been proven to significantly improve the vision performance of Air Force fighter pilots and professional athletes. The app is available as a free download.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Chris Paul","Game Vision app","neuroscience technology","image processing speed","sports vision"],"date_of_event":"March 3, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SfRC5rLBQFJ5J862lon61eJmFNqK4DOUqT2eBApDskeCR9vsi0LErU","news_summary":"Nine-Time All-Star Chris Paul And InnoVision Labs Launch Game Vision App By Chris Paul","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d04ba0b5-18be-4d71-8ecc-55ee4d3efdca","date":"Jan 21, 2016","link":"http://www.prnewswire.com/news-releases/glassesoff-inc-renamed-innovision-labs-inc-new-trading-symbol-invs-566114351.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"product expansion","company":"InnoVision Labs, Inc.","layoffs":null,"summary":"InnoVision Labs, Inc. has announced its new name and trading symbol, along with an expanded product portfolio. The company has developed apps for sports vision processing speed exercises and near vision sharpness training. The brand name GlassesOff™ will continue to be used for the existing mobile application that aims to eliminate dependency on reading glasses, while Game Vision™ will be used for upcoming mobile applications focused on sports vision performance. The first of these apps is set to launch in partnership with Chris Paul, an eight-time all-star basketball player. The companys CEO, Nimrod Madar, emphasized the commitment to innovation and vision performance, with a focus on scientific research and the development of new products. InnoVision Labs is a visual neuroscience technology company that develops and commercializes consumer-oriented software applications.","partners":["Chris Paul"],"customers":null,"investors":null,"confidence":8,"key_topics":["product portfolio","sports app","vision improvement","brand name","partnership"],"date_of_event":"January 21, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nkGEtq8p7sC7264vVSkgVjOodWwfXGVAyMjzMxYynA6Uxjhze3HvPb","news_summary":"GlassesOff Inc. Renamed InnoVision Labs, Inc., New Trading Symbol INVS","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9d6d22d4-486c-426b-a943-910632b092f5","date":"Jul 9, 2014","link":"http://nocamels.com/2014/07/israels-glassesoff-app-said-to-make-eyes-a-whopping-8-6-years-younger/","source":"nocamels.com","visible":1,"analysis":{"tags":"vision improvement","company":"GlassesOff","layoffs":null,"summary":"Israeli startup GlassesOff has developed a mobile app that can train the brain to bypass presbyopia, a condition that affects vision as people age. The app is based on research from Tel Aviv University, which shows that presbyopia is caused by prolonged brain processing time of images, rather than visual clouding. By playing a simple game a few times a week, individuals aged 40-60 can improve their vision. The app constructs a customized training regimen and stimulates the visual cortex in the brain to eliminate visual confusion. The app costs $59.99 for a subscription after a free 2-week trial period.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["GlassesOff","vision improvement","brain training","presbyopia","neuroplasticity"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"M48V5mNXmt6UltSBIIsKckQjCvDzoF8t6wzZzWg7F7zMjk8kENqHeW","news_summary":"Israel's 'GlassesOff' App Said To Make Eyes A Whopping 8.6 Years Younger","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":3,"techcommunityinvolvement":null,"mediagallery":[{"id":"2c940dcc-2026-4a92-8b72-29e4a55694c6","timestamp":"2018-02-27 08:03:18.000000","resources_type":2,"resources_title":"Innovision Labs - Technologies for better vision","resources_file_name":"LSo6Bw_jguA","alt":"Innovision Labs - Technologies for better vision logo","imageurl":"https://img.youtube.com/vi/LSo6Bw_jguA/0.jpg","url":"http://youtu.be/LSo6Bw_jguA"},{"id":"eb26eb69-e36e-4edc-aff6-c5fd4d30a674","timestamp":"2014-07-27 09:19:47.000000","resources_type":2,"resources_title":"","resources_file_name":"12dlMyjatKI","alt":"","imageurl":"https://img.youtube.com/vi/12dlMyjatKI/0.jpg","url":"http://youtu.be/12dlMyjatKI"}],"tags":["gamification","mhealth","mhealth","non-invasive","seniors","mobile-applications","digital-healthcare","personalization","ophthalmology","diagnostics","mobile-games","adhd","sports","games","serious-games","optronics","digital-therapeutics","medical-technologies"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C"],"productstage":"Released","products":["GlassesOff","Game Vision"],"geomarkets":["Global","China"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":1,"lastfunding":"$15M","totalrounds":4,"fundingstage":"Mature","totalfunding":"$23.1M","publicinvestors":1,"lastpublicfunding":15000000,"totalpublicrounds":4,"totalpublicfunding":23100000},"team":[{"name":"Nimrod  Madar","email":"nimrodmadar@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGh5poJDA","bounced":false,"claimed":0,"founder":0,"urlname":"nimrod-madar-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd-E-QkM","position":"Director","last_name":"Madar","claimtoken":"893c28f27ea6bacd992ac158f91d87ae9285bc9152dbbbe36c768d461420b6f8","first_name":"Nimrod ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/nimrod-madar-b178905/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2020-09-21 10:06:11.000000","initials":"NM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2019-12-18T00:00:00.000Z","crunchbaseid":"glassesoff","lastupdator":"Orli Wollner","lastupdator_email":"orlushka@gmail.com","creator":null,"creator_email":null,"createdate":"2014-07-27T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"ExnuXweOi9tAjrn0EF8RDTTDSU2wT3c7xhnAHRvSwjX8oVahsiGyV3","date":"Jan 2017","amount":"Undisclosed","source":"","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"OTCBB","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC44M6OCQw","stockexchange_logokey":"$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEv7SMCQw","date":"Jul 2014","amount":"$15M","source":"https://www.businesswire.com/news/home/20140703005143/en/GlassesOff-Secures-15-Million-Financing-Facility#.U7VW_LFs5dg","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2tCACww","date":"May 2014","amount":"$5M","source":"https://www.businesswire.com/news/home/20140519005799/en/GlassesOff-Announces-Closing-Non-Brokered-5-Million-Private#.U3oCdvmSzcQ","eventtype":"FundingRoundEvent","investment":[{"name":"SG Cowen","type":"Company","amount":0,"hidden":true,"country":"United States","fullurl":"/company_page/sg-cowen","logokey":"$s4nbNpzu59qb26sIz7EyEmPuH5i6DqRD6mOqolRCP1mt5ItQCCfJkG","tagline":"","urlname":"/company_page/sg-cowen","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvJrWCQw","fundingtype":"Company","leadpartner":null,"investmentid":"a2c07a17-f84d-41d5-92f6-698ebb48362d","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$s4nbNpzu59qb26sIz7EyEmPuH5i6DqRD6mOqolRCP1mt5ItQCCfJkG","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkgvzICgw","date":"Aug 2013","amount":"$3.1M","source":"https://www.businesswire.com/news/home/20130806005480/en/GlassesOff-Announces-Closing-Merger-3.1-Million-Private?utm_source=dlvr.it&utm_medium=twitter","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4r-6rCQw","date":"May 2012","amount":"Undisclosed","source":"https://www.prnewswire.com/news-releases/glassesoff-inc-renamed-innovision-labs-inc-new-trading-symbol-invs-566114351.html","ticker":"INVS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"OTCBB","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC44M6OCQw","stockexchange_logokey":"$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"2/2007","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Innovision Labs","logourl":"https://storage.googleapis.com/clean-finder-353810/$uCrHHdpKMqY2DZW9ObBOZ2ibQrkVXk9cNPkonjEtBHlCElCYzzKvhr","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$uCrHHdpKMqY2DZW9ObBOZ2ibQrkVXk9cNPkonjEtBHlCElCYzzKvhr","seoabout":"Innovision Labs is a neuroscience technology company focused on enhancing image-processing functions in the human vision system. The company's team uses br...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":1,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Mobile","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Digital Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Mobile#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Digital Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Mobile#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Digital Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Digital Therapeutics"}]}]}],"targetCustomer":[{"title":"Consumers","key":"0-0","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Seniors","key":"0-0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Seniors"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Mobile","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Mobile"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81bgJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Mobile","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgrgKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Digital Therapeutics"],"coreTechnology":["Platforms & Interfaces","Mobile"],"targetCustomer":["Consumers","Demographics & Family","Seniors"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"ExnuXweOi9tAjrn0EF8RDTTDSU2wT3c7xhnAHRvSwjX8oVahsiGyV3","date":"Jan 2017","amount":"Undisclosed","source":"","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"OTCBB","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC44M6OCQw","stockexchange_logokey":"$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4r-6rCQw","date":"May 2012","amount":"Undisclosed","source":"https://www.prnewswire.com/news-releases/glassesoff-inc-renamed-innovision-labs-inc-new-trading-symbol-invs-566114351.html","ticker":"INVS","eventtype":"POEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"OTCBB","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC44M6OCQw","stockexchange_logokey":"$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$F6AteF1rLeicOMVybfOvaX2f4I6RwJWIRYqdS6oHqf9mfwxvZfhEr1","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEv7SMCQw","date":"Jul 2014","amount":"$15M","source":"https://www.businesswire.com/news/home/20140703005143/en/GlassesOff-Secures-15-Million-Financing-Facility#.U7VW_LFs5dg","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2tCACww","date":"May 2014","amount":"$5M","source":"https://www.businesswire.com/news/home/20140519005799/en/GlassesOff-Announces-Closing-Non-Brokered-5-Million-Private#.U3oCdvmSzcQ","eventtype":"FundingRoundEvent","investment":[{"name":"SG Cowen","type":"Company","amount":0,"hidden":true,"country":"United States","fullurl":"/company_page/sg-cowen","logokey":"$s4nbNpzu59qb26sIz7EyEmPuH5i6DqRD6mOqolRCP1mt5ItQCCfJkG","tagline":"","urlname":"/company_page/sg-cowen","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEvJrWCQw","fundingtype":"Company","leadpartner":null,"investmentid":"a2c07a17-f84d-41d5-92f6-698ebb48362d","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$s4nbNpzu59qb26sIz7EyEmPuH5i6DqRD6mOqolRCP1mt5ItQCCfJkG","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkgvzICgw","date":"Aug 2013","amount":"$3.1M","source":"https://www.businesswire.com/news/home/20130806005480/en/GlassesOff-Announces-Closing-Merger-3.1-Million-Private?utm_source=dlvr.it&utm_medium=twitter","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"PIPE","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3100000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}